The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Molecular Imaging–Based Dose Painting: A Novel Paradigm for Radiation Therapy Prescription
Open accessAbstract
Dose painting is the prescription of a non-uniform radiation dose distribution to the target volume based on functional or molecular images shown to be indicative of the local risk of relapse. Two prototypical strategies for implementing this novel paradigm in radiation oncology are reviewed: sub-volume boosting and dose painting by numbers. Sub-volume boosting involves the selection of a “target within the target”, defined by image segmentation on the basis of the quantitative information in the image or morphologically, and this is related to image based target volume selection and delineation. Dose painting by numbers is a voxel-level prescription of dose based on a mathematical transformation of the image intensity of individual pixels. Quantitative use of images to decide both where and how to delivery radiation therapy in an individual case is also called theragnostic imaging. Dose painting targets are imaging surrogates for cellular or microenvironmental phenotypes associated with poor radioresponsiveness. In this review, the focus is on positron emission tomography (PET) tracers: FDG and choline as surrogates for tumor burden, FLT as a surrogate for proliferation (or cellular growth fraction) and hypoxia sensitive tracers including FMISO, EF3, EF5 and Cu-ATSM as surrogates of cellular hypoxia. Research advances supporting the clinico-biological rationale for dose painting are reviewed as are studies of the technical feasibility of optimizing and delivering realistic dose painted radiation therapy plans. Challenges and research priorities in this exciting research field are defined and a possible design for a randomized clinical trial of dose painting is presented.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hypoxia — a key regulatory factor in tumour growth
Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177 · cited 1×
“FLT and the hypoxic selective (64)Cu-ATSM in a rodent model of cancer.”
BackgroundRadiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
Bonner, J. A., Harari, P. M., Giralt, J., Azarnia, N., Shin, D. M., Cohen, R. B., Jones, C. U., Sur, R., Raben, D., Jassem, J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053422 · Cited by 5,115
Höckel, M., Schlenger, K., Aral, B., Mitze, M., Schäffer, U., & Vaupel, P. W. (1996) · PubMed · Cited by 1,927
Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis
Bourhis, J., Overgaard, J., Audry, H., Ang, K. K., Saunders, M., Bernier, J., Horiot, J.-C., Le Maître, A., Pajak, T. F., Poulsen, M. G., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69121-6 · Cited by 1,085
Nordsmark, M., Bentzen, S. M., Rudat, V., Brizel, D., Lartigau, E., Stadler, P., Becker, A., Adam, M., Molls, M., Dunst, J., et al. (2005) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2005.06.038 · Cited by 953
Self-citationTowards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality
Ling, C. C., Humm, J., Larson, S., Amols, H., Fuks, Z., Leibel, S., & Koutcher, J. A. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)00467-3 · Cited by 926
Repopulation of cancer cells during therapy: an important cause of treatment failure
Kim, J. J., & Tannock, I. F. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1650 · Cited by 686
Daisne, J.-F., Duprez, T., Weynand, B., Lonneux, M., Hamoir, M., Reychler, H., & Grégoire, V. (2004) · Radiology · doi:10.1148/radiol.2331030660 · Cited by 677
Tatum, J. L. (2006) · International Journal of Radiation Biology · doi:10.1080/09553000601002324 · Cited by 620
(2005) · PubMed · Cited by 612
Oxygenation predicts radiation response and survival in patients with cervix cancer
Fyles, A. W., Milosevic, M., Wong, R., Kavanagh, M.-C., Pintilie, M., Sun, A., Chapman, W., Levin, W., Manchul, L., Keane, T. J., et al. (1998) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(98)00044-9 · Cited by 597
Bos, R., van der Hoeven, J. J. M., van der Wall, E., van der Groep, P., van Diest, P. J., Comans, E. F. I., Joshi, U., Semenza, G. L., Hoekstra, O. S., Lammertsma, A. A., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.2.379 · Cited by 591
Saunders, M., Dische, S., Barrett, A., Harvey, A., Gibson, D., & Parmar, M. (1997) · The Lancet · doi:10.1016/s0140-6736(97)06305-8 · Cited by 584
Rasey, J. S., Koh, W.-J., Evans, M. L., Peterson, L. M., Lewellen, T. K., Graham, M. M., & Krohn, K. A. (1996) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(96)00325-2 · Cited by 562
Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole
Koh, W.-J., Rasey, J. S., Evans, M. L., Grierson, J. R., Lewellen, T. K., Graham, M. M., Krohn, K. A., & Griffin, T. W. (1992) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(92)91001-4 · Cited by 463
Imaging proliferation in lung tumors with PET: 18F-FLT versus 18F-FDG.
Buck, A. K., Halter, G., Schirrmeister, H., Kotzerke, J., Wurziger, I., Glatting, G., Mattfeldt, T., Neumaier, B., Reske, S. N., & Hetzel, M. (2003) · PubMed · Cited by 439
Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG.
Chen, W., Cloughesy, T. F., Kamdar, N. V., Satyamurthy, N., Bergsneider, M., Liau, L. M., Mischel, P. S., Czernin, J., Phelps, M. E., & Silverman, D. H. S. (2005) · PubMed · Cited by 437
A gradient-based method for segmenting FDG-PET images: methodology and validation
Geets, X., Lee, J. A., Bol, A., Lonneux, M., & Grégoire, V. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-006-0363-4 · Cited by 419
Theragnostic imaging for radiation oncology: dose-painting by numbers
Bentzen, S. M. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)01737-7 · Cited by 416
Self-citationValidation of FLT uptake as a measure of thymidine kinase-1 activity in A549 carcinoma cells.
Rasey, J. S., Grierson, J. R., Wiens, L. W., Kolb, P. D., & Schwartz, J. L. (2002) · PubMed · Cited by 406
Hypoxia Dose Painting by Numbers: A Planning Study
Thorwarth, D., Eschmann, S.-M., Paulsen, F., & Alber, M. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.11.061 · Cited by 301
Vesselle, H. J., Grierson, J. R., Muzi, M., Pugsley, J. M., Schmidt, R. A., Rabinowitz, P., Peterson, L. M., Vallières, E., & Wood, D. E. (2002) · PubMed · Cited by 300
van Baardwijk, A., Bosmans, G., Boersma, L., Buijsen, J., Wanders, S., Hochstenbag, M., van Suylen, R.-J., Dekker, A., Dehing-Oberije, C., Houben, R., et al. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.12.067 · Cited by 295
Self-citationKoukourakis, M. I., Bentzen, S. M., Giatromanolaki, A., Wilson, G. D., Daley, F. M., Saunders, M. I., Dische, S., Sivridis, E., & Harris, A. L. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.7474 · Cited by 289
Self-citationVergis, R., Corbishley, C. M., Norman, A. R., Bartlett, J., Jhavar, S., Borre, M., Heeboll, S., Horwich, A., Huddart, R., Khoo, V., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70076-7 · Cited by 282
Bentzen, S. M., Atasoy, B. M., Daley, F. M., Dische, S., Richman, P. I., Saunders, M. I., Trott, K. R., & Wilson, G. D. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.411 · Cited by 249
Self-citationLee, N. Y., Mechalakos, J. G., Nehmeh, S., Lin, Z., Squire, O. D., Cai, S., Chan, K., Zanzonico, P. B., Greco, C., Ling, C. C., et al. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.06.039 · Cited by 235
Dehdashti, F., Grigsby, P. W., Lewis, J. S., Laforest, R., Siegel, B. A., & Welch, M. J. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.048520 · Cited by 212
Reproducibility of Intratumor Distribution of 18F-Fluoromisonidazole in Head and Neck Cancer
Nehmeh, S. A., Lee, N. Y., Schröder, H., Squire, O., Zanzonico, P. B., Erdi, Y. E., Greco, C., Mageras, G., Pham, H. S., Larson, S. M., et al. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.08.036 · Cited by 210
Dirix, P., Vandecaveye, V., De Keyzer, F., Stroobants, S., Hermans, R., & Nuyts, S. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.062638 · Cited by 207
Molecular imaging of hypoxia with radiolabelled agents
Mees, G., Dierckx, R., Vangestel, C., & Van de Wiele, C. (2009) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-009-1195-9 · Cited by 201
Movsas, B., Chapman, J. D., Hanlon, A. L., Horwitz, E. M., Greenberg, R. E., Stobbe, C., Hanks, G. E., & Pollack, A. (2002) · Urology · doi:10.1016/s0090-4295(02)01858-7 · Cited by 188
Zhao, S., Kuge, Y., Mochizuki, T., Takahashi, T., Nakada, K., Sato, M., Takei, T., & Tamaki, N. (2005) · PubMed · Cited by 175
Yap, C. S., Czernin, J., Fishbein, M. C., Cameron, R. B., Schiepers, C., Phelps, M. E., & Weber, W. A. (2006) · Chest · doi:10.1378/chest.129.2.393 · Cited by 166
van der Wel, A. M., Nijsten, S. M. J. J. G., Hochstenbag, M. M. H., Lamers, R. J. S., Boersma, L. J., Wanders, R., Lutgens, L. C. H. W., Zimny, M., Bentzen, S. M., Wouters, B. G., et al. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2004.06.205 · Cited by 165
Self-citationGeets, X., Tomsej, M., Lee, J. A., Duprez, T., Coche, E., Cosnard, G., Lonneux, M., & Grégoire, V. (2007) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2007.05.010 · Cited by 163
Begg, A. C., Haustermans, K. M., Hart, A. A. M., Dische, S., Saunders, M. I., Zackrisson, B., Gustaffson, H., Coucke, P. A., Paschoud, N., Høyer, M., et al. (1999) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(98)00147-9 · Cited by 162
18F-FLT PET/CT for Early Response Monitoring and Dose Escalation in Oropharyngeal Tumors
Troost, E. G. C., Bussink, J., Hoffmann, A. L., Boerman, O. C., Oyen, W. J. G., & Kaanders, J. H. A. M. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.069310 · Cited by 158
Yamamoto, Y., Nishiyama, Y., Ishikawa, S., Nakano, J., Chang, S. S., Bandoh, S., Kanaji, N., Haba, R., Kushida, Y., & Ohkawa, M. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0449-7 · Cited by 147
Comparison of 18F-FLT PET and 18F-FDG PET in esophageal cancer.
van Westreenen, H. L., Cobben, D., Jager, P. L., van Dullemen, H. M., Wesseling, J., Elsinga, P. H., & Plukker, J. T. M. (2005) · PubMed · Cited by 144
Ruysscher, D. D., Wanders, S. L., Minken, A., Lumens, A., Schiffelers, J., Stultiens, C., Halders, S. G. E. A., Boersma, L. J., van Baardwijk, A. A. W., Verschueren, T. A. M., et al. (2005) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2005.06.014 · Cited by 140
Self-citationLee, N. Y., Nehmeh, S. A., Schöder, H. M., Fury, M. G., Chan, K., Ling, C. C., & Humm, J. L. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.10.049 · Cited by 128
Cellular uptake of PET tracers of glucose metabolism and hypoxia and their linkage
Busk, M., Horsman, M. R., Jakobsen, S., Bussink, J., van der Kogel, A., & Overgaard, J. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-008-0888-9 · Cited by 112
PET for radiation treatment planning of brain tumours
Grosu, A., & Weber, W. (2010) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2010.08.001 · Cited by 102
Feasibility of Pathology-Correlated Lung Imaging for Accurate Target Definition of Lung Tumors
Stroom, J. C., Blaauwgeers, H., van Baardwijk, A. A. W., Boersma, L. J., Lebesque, J. V., Theuws, J. C. M., van Suylen, R. J., Klomp, H. M., Liesker, K. R., van Pel, R., et al. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.04.065 · Cited by 97
Popple, R. A., Ove, R., & Shen, S. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)03007-9 · Cited by 97
Barwick, T. D., Bencherif, B., Mountz, J. M., & Avril, N. E. (2009) · Nuclear Medicine Communications · doi:10.1097/mnm.0b013e32832ee93b · Cited by 93
Søvik, Å., Malinen, E., Bruland, Ø. S., Bentzen, S. M., & Olsen, D. R. (2006) · Physics in Medicine and Biology · doi:10.1088/0031-9155/52/2/013 · Cited by 93
Self-citationCarnell, D. M., Smith, R. E., Daley, F. M., Saunders, M. I., Bentzen, S. M., & Hoskin, P. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.11.044 · Cited by 89
Self-citationStewart, G. D. (1994) · Oncology Reports · doi:10.3892/or_00000180 · Cited by 89
Dence, C. S., Ponde, D. E., Welch, M. J., & Lewis, J. S. (2008) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2008.06.001 · Cited by 85
Yue, J., Chen, L., Cabrera, A. R., Sun, X., Zhao, S., Fu, Z., Han, A., Zheng, J., Teng, X., Ma, L., et al. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.072124 · Cited by 82
Adapting radiotherapy to hypoxic tumours
Malinen, E., Søvik, Å., Hristov, D. H., Bruland, Ø. S., & Olsen, D. R. (2006) · Physics in Medicine and Biology · doi:10.1088/0031-9155/51/19/012 · Cited by 79
Apisarnthanarax, S., Alauddin, M. M., Mourtada, F., Ariga, H., Raju, U., Mawlawi, O. R., Han, D., Bornmann, W. G., Ajani, J. A., Milas, L., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2720 · Cited by 76
Imaging of EGFR and EGFR Tyrosine Kinase Overexpression in Tumors by Nuclear Medicine Modalities
Mishani, E., Abourbeh, G., Eiblmaier, M., & Anderson, C. J. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208786404326 · Cited by 76
Monitoring of therapy in androgen-dependent prostate tumor model by measuring tumor proliferation.
Oyama, N., Ponde, D. E., Dence, C. S., Kim, J., Tai, Y., & Welch, M. J. (2004) · PubMed · Cited by 76
Radiotherapy Adapted to Spatial and Temporal Variability in Tumor Hypoxia
Søvik, Å., Malinen, E., Skogmo, H. K., Bentzen, S. M., Bruland, Ø. S., & Olsen, D. R. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.04.027 · Cited by 75
Self-citationYang, Y.-J., Ryu, J., Kim, S.-Y., Oh, S. J., Im, K. C., Lee, H., Lee, S.-W., Cho, K. J., Cheon, G. J., & Moon, D. H. (2006) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-005-0011-4 · Cited by 71
Repopulation in radiation oncology: perspectives of clinical research
Bentzen, S. M. (2003) · International Journal of Radiation Biology · doi:10.1080/09553000310001597002 · Cited by 63
Self-citationWebb, S., Evans, P., Swindell, W. H., & Deasy, J. O. (1994) · Physics in Medicine and Biology · doi:10.1088/0031-9155/39/11/018 · Cited by 59
Feasibility of dose painting using volumetric modulated arc optimization and delivery
Korreman, S., Ulrich, S., Bowen, S., Deveau, M. A., Bentzen, S. M., & Jeraj, R. (2010) · Acta Oncologica · doi:10.3109/0284186x.2010.498440 · Cited by 53
Self-citationClinical evidence on PET/CT for radiation therapy planning in prostate cancer
Picchio, M., Giovannini, E., Crivellaro, C., Gianolli, L., Muzio, N. G. D., & Messa, C. (2010) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2010.07.016 · Cited by 46
Bentzen, S. M. (2007) · Cancer treatment and research · doi:10.1007/978-0-387-36744-6_3 · Cited by 46
Self-citationChristian, N., Deheneffe, S., Bol, A., Bast, M. D., Labar, D., Lee, J. A., & Grégoire, V. (2010) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2010.02.020 · Cited by 42
Mahy, P., Bast, M. D., de Groot, T., Cheguillaume, A., Gillart, J., Haustermans, K. M., Labar, D., & Grégoire, V. (2008) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2008.06.008 · Cited by 26
Cited by
Nanomaterials for In Vivo Imaging
Smith, B. R., & Gambhir, S. S. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00073 · Cited by 1,075
Limkin, E. J., Sun, R., Dercle, L., Zacharaki, E. I., Robert, C., Reuzé, S., Schernberg, A., Paragios, N., Deutsch, E., & Ferté, C. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx034 · Cited by 757
Imaging hypoxia to improve radiotherapy outcome
Horsman, M. R., Mortensen, L. S., Petersen, J. B., Busk, M., & Overgaard, J. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.171 · Cited by 614
A Plasmonic Gold Nanostar Theranostic Probe for In Vivo Tumor Imaging and Photothermal Therapy
Liu, Y., Ashton, J. R., Moding, E. J., Yuan, H., Register, J. K., Fales, A. M., Choi, J., Whitley, M. J., Zhao, X., Qi, Y., et al. (2015) · Theranostics · doi:10.7150/thno.11974 · Cited by 308
A method for estimating the oxygen consumption rate in multicellular tumour spheroids
Grimes, D. R., Kelly, C., Bloch, K., & Partridge, M. (2014) · Journal of The Royal Society Interface · doi:10.1098/rsif.2013.1124 · Cited by 297
Metadata
- Authors
- Bentzen, S. M., & Gregoire, V.
- Venue
- Seminars in Radiation Oncology
- Publisher
- Elsevier BV
- Published
- 2011-04
- Volume
- 21
- Issue
- 2
- Pages
- 101-110
- ISSN
- 1053-4296 (ISSN-L)
- OpenAlex
- W2025633794
- Cited by
- 307
- References
- 65
- FWCI
- 28.61
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.